WS
GMED icon

Wedbush Securities’s Globus Medical GMED Stock Holding History

Wedbush Securities’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,994
Closed -$292K – 1170
2025
Q1 		$292K Buy
+3,994
New +$330K 0.01% 829

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Wedbush Securities's GMED Position: Q2 2025 in Review

Wedbush Securities sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 3,994 shares — an estimated $292K sold.

Wedbush Securities first reported a position in GMED in Q1 2025 and held it in 1 quarter. The position peaked at $292K in Q1 2025. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Wedbush Securities reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Wedbush Securities sold 3,994 Globus Medical shares in Q2 2025, an estimated $292K.
  • Wedbush Securities first reported a position in Globus Medical in Q1 2025 and held it in 1 quarter.
  • Wedbush Securities's Globus Medical position peaked at $292K in Q1 2025.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Wedbush Securities's 13F filing for Q2 2025, filed 6 Aug 2025.